We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Algorithm Allows for Better Heart Surgery

By HospiMedica International staff writers
Posted on 21 Jan 2015
A new computational technique can identify the origin of ectopic atrial activity by using a more complete 64-lead electrocardiogram (ECG) configuration.

Developed by researchers at Manchester University (United Kingdom), the algorithm was derived from a biophysically detailed three dimensional (3-D) computational model of the human atria and torso. More...
The researchers simulated electrical activity during normal sinus rhythm and ectopic pacing to analyze how atrial excitation was reflected in alteration to the P-wave morphology (PWM). The researchers thus created an ECG map that detects the origin of the heart defect, reducing the amount of time some patients need to spend in surgery.

The researchers found that during sinus rhythm, the simulated P-waves of 12 and 64 leads ECG and body-surface potential (BSP) dipole direction show strong agreement with experimental data. Marked changes in PWM were associated with ectopic atrial activity, with some areas of the torso being more sensitive to specific activity than others. The success rate of the algorithm was 93%, correctly identifying the origin of the problems in 75 out of 80 simulations, a much better rate than current technology. The study was published on January 8, 2015, in PLoS Computational Biology.

“The standard way we do electrocardiograms does not provide sufficient information to enable medical professionals to focus in clearly to the area of concern,” said lead author, Professor of Biological Physics Henggui Zhang, PhD. “What we have come up with here is a significant improvement over previous techniques. Using this new algorithm ECG map can help diagnose the location of cardiac disorder in a way which is better for the patients and more cost effective for health services.”

ECG body surface mapping (BSM) is a technique that uses multiple electrocardiography leads to detect electrical activity. The use of multiple leads can result in improved diagnostic accuracy compared to that of the standard 12-lead ECG. Currently there are no BSM ECG devices with 80 or more leads commercially available in the United States.

Related Links:

Manchester University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.